<DOC>
	<DOCNO>NCT00268320</DOCNO>
	<brief_summary>Heart failure progressive disease decrease pump action heart . This may cause backup fluid heart may result heart beat change . When change heart beat sometimes implantable heart device use control rate rhythm heart beat . In certain heart failure case , two low chamber heart longer beat coordinated manner , cardiac resynchronization therapy may prescribe . People dangerously fast heart beat , whose heart risk stop beating , may need electronic device call implantable cardioverter defibrillator ( ICD ) . Atrial tachyarrhythmia ( AT ) name rapid beat upper chamber heart . People AT may experience symptom heart palpitation ( race pound feel chest ) , shortness breath , dizziness , fatigue weakness . The purpose study study investigational implantable device contain Cardiac Resynchronization Therapy ( CRT ) Implantable Cardioverter Defibrillator ( ICD ) therapy ( CRT+ICD device ) subject significant risk develop atrial tachyarrhythmias .</brief_summary>
	<brief_title>Clinical Investigation Medtronic Concerto™ Device</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Tachycardia</mesh_term>
	<criteria>Subjects require implantation Implantable Cardioverter Defibrillator Subjects heart failure severely limits daily activity ( NYHA Class III ) Subjects severe heart failure always rest ( NYHA Class IV ) Subjects reduced heart pump function ( left ventricular ejection fraction ≤ 35 % ) Subjects constant atrial fibrillation ( top chamber heart beat fast continuously ) Subjects postheart transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2008</verification_date>
	<keyword>congestive heart failure , atrial arrhythmia , cardiac resynchronization therapy , implantable cardioverter defibrillator</keyword>
</DOC>